These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25533880)

  • 1. Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review.
    Falagas ME; Trigkidis KK; Vardakas KZ
    Int J Antimicrob Agents; 2015 Mar; 45(3):221-33. PubMed ID: 25533880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosolized Antibiotics.
    Restrepo MI; Keyt H; Reyes LF
    Respir Care; 2015 Jun; 60(6):762-1; discussion 771-3. PubMed ID: 26070573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled antibiotics for lower airway infections.
    Quon BS; Goss CH; Ramsey BW
    Ann Am Thorac Soc; 2014 Mar; 11(3):425-34. PubMed ID: 24673698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the efficacy of aztreonam for inhalation solution in the management of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Hansen C; Skov M
    Ther Adv Respir Dis; 2015 Feb; 9(1):16-21. PubMed ID: 25471692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled colistin for lower respiratory tract infections.
    Antoniu SA; Cojocaru I
    Expert Opin Drug Deliv; 2012 Mar; 9(3):333-42. PubMed ID: 22332963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing inhaled colistin with inhaled fosfomycin/tobramycin as an adjunctive treatment for ventilator-associated pneumonia: An open-label randomized controlled trial.
    Hakamifard A; Torfeh Esfahani AA; Homayouni A; Khorvash F; Ataei B; Abbasi S
    Clin Respir J; 2023 Apr; 17(4):295-302. PubMed ID: 36775964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyxins for the treatment of lower respiratory tract infections: lessons learned from the integration of clinical pharmacokinetic studies and clinical outcomes.
    Almangour TA; Garcia E; Zhou Q; Forrest A; Kaye KS; Li J; Velkov T; Rao GG
    Int J Antimicrob Agents; 2021 Jun; 57(6):106328. PubMed ID: 33785362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis.
    Antoniu S
    Expert Rev Anti Infect Ther; 2015 Jul; 13(7):897-905. PubMed ID: 25921312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel amikacin inhaled formulation for the treatment of lower respiratory tract infections.
    Antoniu S; Azoicai D
    Drugs Today (Barc); 2013 Nov; 49(11):683-92. PubMed ID: 24308015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis.
    Tay GT; Reid DW; Bell SC
    Semin Respir Crit Care Med; 2015 Apr; 36(2):267-86. PubMed ID: 25826593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled anti-infective agents: emphasis on colistin.
    Michalopoulos A; Papadakis E
    Infection; 2010 Apr; 38(2):81-8. PubMed ID: 20191398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled antibiotics to treat lung infection.
    Cipolla D; Chan HK
    Pharm Pat Anal; 2013 Sep; 2(5):647-63. PubMed ID: 24237172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis.
    MacLeod DL; Barker LM; Sutherland JL; Moss SC; Gurgel JL; Kenney TF; Burns JL; Baker WR
    J Antimicrob Chemother; 2009 Oct; 64(4):829-36. PubMed ID: 19679597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled antibiotics for lower respiratory tract infections: focus on ciprofloxacin.
    Serisier DJ
    Drugs Today (Barc); 2012 May; 48(5):339-51. PubMed ID: 22645722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why don't we have more inhaled antibiotics to treat ventilator-associated pneumonia?
    Sweeney DA; Kalil AC
    Clin Microbiol Infect; 2019 Oct; 25(10):1195-1199. PubMed ID: 31035015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.
    Fjaellegaard K; Sin MD; Browatzki A; Ulrik CS
    Chron Respir Dis; 2017 May; 14(2):174-186. PubMed ID: 27507832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review.
    Heffernan AJ; Sime FB; Lipman J; Dhanani J; Andrews K; Ellwood D; Grimwood K; Roberts JA
    Int J Antimicrob Agents; 2019 Mar; 53(3):234-245. PubMed ID: 30472292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhaled antibiotics in the treatment of noncystic fibrosis bronchiectasis].
    Martínez García MÁ; Soler Cataluña JJ; Serra PC
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():19-23. PubMed ID: 21703475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.